Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 2,718 | 2,707 | 2,335 | 3,523 | 3,632 |
| Cost of Goods | 1,968 | 1,746 | 1,662 | 2,662 | 2,378 |
| Gross Profit | 750 | 961 | 673 | 861 | 1,254 |
| Operating Expenses | 2,960 | 2,720 | 2,751 | 3,215 | 3,164 |
| Operating Income | -1,242 | -1,013 | -1,417 | -1,693 | -1,532 |
| Interest Expense | -25 | 8 | 8 | 6 | 7 |
| Other Income | -33 | 0 | 0 | 0 | 1 |
| Pre-tax Income | -1,250 | -1,021 | -1,424 | -1,699 | -1,538 |
| Net Income Continuous | -1,250 | -1,021 | -1,424 | -1,699 | -1,538 |
| Net Income | $-1,250 | $-1,021 | $-1,424 | $-1,699 | $-1,538 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.06 | -0.06 | -0.06 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.05 | -0.05 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.06 | -0.06 | -0.06 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.05 | -0.05 | -0.05 |
| EBITDA(a) | $-1,216 | $-952 | $-1,332 | $-1,607 | $-1,447 |